Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

88.97 -1.06 (-1.18%)
Streaming Delayed Price Updated: 10:04 AM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
20 21 Next >
News headline image
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review ↗
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. 
Via Investor's Business Daily
News headline image
Top 4 Health Care Stocks That May Plunge This Month ↗
 
Via Benzinga
News headline image
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating ↗
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier. 
Via Investor's Business Daily
News headline image
(BSX) - Analyzing Boston Scientific's Short Interest ↗
 
Via Benzinga
News headline image
Key Takeaways From Boston Scientific Analyst Ratings ↗
 
Via Benzinga
News headline image
Unveiling 13 Analyst Insights On Boston Scientific ↗
 
Via Benzinga
News headline image
Looking Into Boston Scientific's Recent Short Interest ↗
 
Via Benzinga
News headline image
Wabtec Rumbles onto Stock Spotlight List. Check These Lists For Best Stocks To Watch And Buy ↗
Wabtec leads a diverse group climbing aboard the Stock Spotlight list, including defense and aerospace play TransDigm. 
Via Investor's Business Daily
News headline image
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars ↗
Boston Scientific reports impressive Q1 earnings, with revenues of $3.86 billion, beating estimates. Cardiovascular segment leads with $2.4 billion sales, up 15.9%. Outlook: 2024 net sales growth... 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today ↗
 
Via Benzinga
News headline image
NYSE:BSX may be ready to breakout. ↗
Will BOSTON SCIENTIFIC CORP breakout? 
Via Chartmill
News headline image
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today ↗
 
Via Benzinga
News headline image
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday? ↗
Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the... 
Via Benzinga
Topics Bonds
News headline image
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
17 Analysts Have This To Say About Boston Scientific ↗
 
Via Benzinga
News headline image
BSX Stock Earnings: Boston Scientific Beats EPS, Beats Revenue for Q1 2024 ↗
BSX stock results show that Boston Scientific beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Boston Scientific Pops Into Buy Zones On Solid First-Quarter Report ↗
Boston Scientific heads for two different buy zones after topping Q1 views and hoisting guidance above expectations. 
Via Investor's Business Daily
News headline image
Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally ↗
Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ:TSLA) and semiconductor m 
Via Benzinga
News headline image
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' ↗
Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major... 
Via Benzinga
News headline image
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week ↗
Corporate profit growth rose in Q3 2023 and is expected to continue in Q1. 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA ↗
BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in... 
Via Benzinga
Topics Supply Chain
News headline image
5 Things to Know in Investing This Week ↗
The Shockwave Issue 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst ↗
Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interest in expanding into cardiovascular devices. Piper Sandler considers J&J a potential... 
Via Benzinga
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
A look at five stocks that are seeing increased attention from investors and Benzinga readers. The list includes several large cap stocks for the week. 
Via Benzinga
News headline image
Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst ↗
Fellow infant formula maker Reckitt Benckiser was ordered to pay $60 million to a mother whose baby died after eating Enfamil. 
Via Investor's Business Daily
Topics Death
News headline image
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher ↗
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78. 
Via Investor's Business Daily
News headline image
The Hot List: 3 AI Stocks Worth Buying on Weakness ↗
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness. 
Via InvestorPlace
Topics Artificial Intelligence
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.